Application of growth hormone in the treatment of hyperopia

Abstract

The present invention discloses the use of at least one growth-active substance selected from the following (a) and (b), or a pharmaceutically acceptable salt, prodrug, metabolite, or mimic / analog thereof, in the preparation of a medicament, pharmaceutical composition, or formulation for improving, correcting, alleviating, controlling, treating, or preventing ophthalmic diseases or symptoms:(a) growth hormone; (b) growth hormone secretagogue. By administering an effective amount of the growth-active substance to a patient, it can significantly improve ophthalmic conditions, especially hyperopia and related symptoms, achieving preventive and therapeutic effects against hyperopia, with good safety and promising clinical application prospects. The present invention also provides pharmaceutical compositions, formulations, and devices containing the aforementioned growth hormone-active substances.

Images